Thomas Pietschmann

28PUBLICATIONS
140CO-AUTHORS
Disease surveillanceMedical virologyMajor global burdens of diseaseCheminformatics and quantitative structure-activity relationshipsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 09, 2025
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.

Toni Luise Meister, Maximilian K Nocke, Natalie Heinen

|Feb 26, 2025
Broadly neutralizing antibodies isolated from HEV convalescents confer protective effects in human liver-chimeric mice.

George Ssebyatika, Katja Dinkelborg, Luisa J Ströh

|Dec 15, 2024
Dynamic Combinatorial Chemistry Unveils Nsp10 Inhibitors with Antiviral Potential Against SARS-CoV-2.

Ravindra P Jumde, Gwenaëlle Jézéquel, Margarida Saramago

|Dec 06, 2024
Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies.

Kumar Nagarathinam, Andreas Scheck, Maurice Labuhn

|Feb 08, 2024
Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor.

Svenja M Sake, Xiaoyu Zhang, Manoj Kumar Rajak

Pageof 5